Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 67 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 8618106

    Protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted
  2. US 8609648

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted
  3. US 8609661

    Pyrimido-pyrrolo-quinoxalinedione inhibitors of cystic fibrosis transmembrane conductance regulator protein and uses therefor

    The Regents of the University of California · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted
  4. US 8609650

    Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted
  5. US 8609848

    Pyrazolone-derivatives and their use as PDE-4 inhibitors

    TAKEDA GMBH · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted
  6. US 8598312

    Inhibitors of antigen presentation by MHC class II molecules

    Provid Pharmaceuticals Inc. · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted
  7. US 8598210

    Prolyl hydroxylase inhibitors and methods of use

    Akebia Therapeutics, Inc. · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted
  8. US 8592577

    Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted
  9. US 8586536

    Neprilysin inhibitors

    Theravance, Inc. · Granted Nov 19, 2013 · Expires Nov 14, 2033

    granted
  10. US 8580773

    Small-molecule inhibitors of the androgen receptor

    The Regents of the University of California · Granted Nov 12, 2013 · Expires Nov 7, 2033

    granted
  11. US 8580802

    Pyrrolo[2,3-D]pyrimidines as inhibitors of Janus kinases

    Vertex Pharmaceuticals Incorporated · Granted Nov 12, 2013 · Expires Nov 7, 2033

    granted
  12. US 8580822

    Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors

    REVIVA PHARMACEUTICALS, INC. · Granted Nov 12, 2013 · Expires Nov 7, 2033

    granted
  13. US 8580844

    Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities

    Georgia Regents Research Institute, Inc. · Granted Nov 12, 2013 · Expires Nov 7, 2033

    granted
  14. US 8580852

    2-oxamide inhibitors of phospholipase A2 activity and cellular arachidonate release based on dipeptides and pseudopeptides

    The Regents of the University of California · Granted Nov 12, 2013 · Expires Nov 7, 2033

    granted
  15. AU 2012249536

    Methods and compositions using PDE4 inhibitors for the treatment and management of autoimmune and inflammatory diseases

    CELGENE CORP [CH] · Granted Nov 7, 2013 · Expires Nov 2, 2033

    granted
  16. US 8575208

    Inhibitors of serine proteases

    Vertex Pharmaceuticals Incorporated · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted
  17. US 8569337

    Tri-cyclic pyrazolopyridine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 29, 2013 · Expires Oct 24, 2033

    granted
  18. US 8563576

    Tri-cyclic pyrazolopyridine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted
  19. US 8563512

    Neprilysin inhibitors

    Theravance, Inc. · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted
  20. US 8563559

    Pinane-substituted pyrimidinediamine derivatives useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted
  21. US 8557812

    Small molecule inhibitors of anti-apoptotic BCL-2 family members and the uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted
  22. US 8557818

    Compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted
  23. US 8557800

    Sphingosine kinase inhibitors

    Apogee Biotechnology Corporation · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted
  24. US 8557552

    Selective neuronal nitric oxide synthase inhibitors

    Northwestern University · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted